Literature DB >> 9735080

Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients.

D J Cook1, S D Walter, R J Cook, L E Griffith, G H Guyatt, D Leasa, R Z Jaeschke, C Brun-Buisson.   

Abstract

BACKGROUND: Understanding the risk factors for ventilator-associated pneumonia can help to assess prognosis and devise and test preventive strategies.
OBJECTIVE: To examine the baseline and time-dependent risk factors for ventilator-associated pneumonia and to determine the conditional probability and cumulative risk over the duration of stay in the intensive care unit.
DESIGN: Prospective cohort study.
SETTING: 16 intensive care units in Canada. PATIENTS: 1014 mechanically ventilated patients. MEASUREMENTS: Demographic and time-dependent variables reflecting illness severity, ventilation, nutrition, and drug exposure. Pneumonia was classified by using five methods: adjudication committee, bedside clinician's diagnosis, Centers for Disease Control and Prevention definition, Clinical Pulmonary Infection score, and positive culture from bronchoalveolar lavage or protected specimen brush.
RESULTS: 177 of 1014 patients (17.5%) developed ventilator-associated pneumonia 9.0 +/- 5.9 days (median, 7 days [interquartile range, 5 to 10 days]) after admission to the intensive care unit. Although the cumulative risk increased over time, the daily hazard rate decreased after day 5 (3.3% at day 5, 2.3% at day 10, and 1.3% at day 15). Independent predictors of ventilator-associated pneumonia in multivariable analysis were a primary admitting diagnosis of burns (risk ratio, 5.09 [95% CI, 1.52 to 17.03]), trauma (risk ratio, 5.00 [CI, 1.91 to 13.11]), central nervous system disease (risk ratio, 3.40 [CI, 1.31 to 8.81]), respiratory disease (risk ratio, 2.79 [CI, 1.04 to 7.51]), cardiac disease (risk ratio, 2.72 [CI, 1.05 to 7.01]), mechanical ventilation in the previous 24 hours (risk ratio, 2.28 [CI, 1.11 to 4.68]), witnessed aspiration (risk ratio, 3.25 [CI, 1.62 to 6.50]), and paralytic agents (risk ratio, 1.57 [CI, 1.03 to 2.39]). Exposure to antibiotics conferred protection (risk ratio, 0.37 [CI, 0.27 to 0.51]). Independent risk factors were the same regardless of the pneumonia definition used.
CONCLUSIONS: The daily risk for pneumonia decreases with increasing duration of stay in the intensive care unit. Witnessed aspiration and exposure to paralytic agents are potentially modifiable independent risk factors. Exposure to antibiotics was associated with low rates of early ventilator-associated pneumonia, but this effect attenuates over time.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735080     DOI: 10.7326/0003-4819-129-6-199809150-00002

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  158 in total

Review 1.  Diagnosis of pneumonia and monitoring of infection eradication.

Authors:  M Ruiz; C Arosio; P Salman; T T Bauer; A Torres
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 2.  Ventilator induced lung injury and infection in the critically ill.

Authors:  S V Baudouin
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

3.  Nosocomial Pneumonia: More Than Just Ventilator-Associated.

Authors:  Joseph R. Lentino
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

4.  Etomidate increases susceptibility to pneumonia in trauma patients.

Authors:  Karim Asehnoune; Pierre Joachim Mahe; Philippe Seguin; Samir Jaber; Boris Jung; Christophe Guitton; Nolwen Chatel-Josse; Aurelie Subileau; Anne Charlotte Tellier; Françoise Masson; Benoit Renard; Yannick Malledant; Corinne Lejus; Christelle Volteau; Véronique Sébille; Antoine Roquilly
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

5.  Ventilator-associated pneumonia in ARDS patients: the impact of prone positioning. A secondary analysis of the PROSEVA trial.

Authors:  L Ayzac; R Girard; L Baboi; P Beuret; M Rabilloud; J C Richard; C Guérin
Journal:  Intensive Care Med       Date:  2015-12-23       Impact factor: 17.440

6.  Proinflammatory cytokine surge after injury stimulates an airway immunoglobulin a increase.

Authors:  Mark A Jonker; Yoshifumi Sano; Joshua L Hermsen; Jinggang Lan; Kenneth A Kudsk
Journal:  J Trauma       Date:  2010-10

7.  B-type natriuretic peptide and weaning from mechanical ventilation.

Authors:  Armand Mekontso-Dessap; Nicolas de Prost; Emmanuelle Girou; François Braconnier; François Lemaire; Christian Brun-Buisson; Laurent Brochard
Journal:  Intensive Care Med       Date:  2006-08-29       Impact factor: 17.440

8.  A Bayesian decision-support system for diagnosing ventilator-associated pneumonia.

Authors:  Carolina A M Schurink; Stefan Visscher; Peter J F Lucas; Henk J van Leeuwen; Erik Buskens; Reinier G Hoff; Andy I M Hoepelman; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2007-06-16       Impact factor: 17.440

9.  Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study.

Authors:  A Acquarolo; T Urli; G Perone; C Giannotti; A Candiani; N Latronico
Journal:  Intensive Care Med       Date:  2005-03-08       Impact factor: 17.440

10.  Physiotherapy does not prevent, or hasten recovery from, ventilator-associated pneumonia in patients with acquired brain injury.

Authors:  Shane Patman; Sue Jenkins; Kathy Stiller
Journal:  Intensive Care Med       Date:  2008-09-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.